RECRUITING Not applicable ClinicalTrials.gov

The Effect of Cognitive Exercise Therapy Approach and Yoga in Adolescents With Dysmenorrhoea

Sponsor: Acibadem University • ClinicalTrials.gov ID: NCT06398990

Registry updated: 2026-10-13

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

Dysmenorrhoea is a condition that negatively affects the quality of life in women of many age groups. In girls with dysmenorrhoea in adolescence, there is an effect on school performance, self-confidence-depression problems and a decrease in quality of life due to pain. In order to eliminate these negative effects, they should receive a good treatment. Medical treatment usually tries to minimise and balance this situation. Considering the fact that families do not want to use drugs such as oral contraceptives in their children at this age and the risks of oral contraceptives, parents are in different searches. Considering that the approach to pain should always be from a holistic perspective, yoga and cognitive exercise therapy approaches are both biopsychosocial treatment methods within the scope of mind-body integrity. Yoga and cognitive exercise therapy approach is thought to reduce symptoms, improve physical functions and quality of life in adolescent girls. With these positive effects, school absenteeism decreases, depression and self-confidence improve. Health costs will also be reduced to some extent.

Interventions

Cognitive Exercise Therapy Approach (Other)
It will continue twice a week for 12 weeks. After the initial evaluation of the cases, one-on-one, face-to-face training will be provided with the patient in the first week (2 sessions) in order to ensure their compliance with the treatment and to fully understand the treatment method. Then, treatments will be carried out synchronously with the patients twice a week via the online platform (Zoom).
Yoga (Other)
It will continue twice a week for 12 weeks. After the initial evaluation of the cases, one-on-one, face-to-face training will be provided with the patient in the first week (2 sessions) in order to ensure their compliance with the treatment and to fully understand the treatment method. Then, treatments will be carried out synchronously with the patients twice a week via the online platform (Zoom).
Routine Medical Treatment (Other)
Assessments of individuals in this group will be made face-to-face in the relevant clinic.

Eligibility criteria

Inclusion Criteria: * Between the ages of 10 and 19, * Having had a menstrual cycle for at least 6-12 months (ACOG, 2018), * Having menstrual pain intensity of ≥4 cm according to the Visual Analog Scale (VAS, 0-10 cm) (Kannan, P. 2015; Yonglitthipagon, P. 2017), * To have been diagnosed with primary dysmenorrhea according to the clinical characteristics and diagnostic approach defined in international dysmenorrhea guidelines (ACOG 2018; JOGC 2017), * Nulliparous (having never given birth), * Able to read and write in Turkish, * Willing to participate in the study and having provided informed consent. Exclusion Criteria: * History or clinical findings suggestive of secondary dysmenorrhea, * Presence of serious comorbidities, including neurological, cardiovascular, musculoskeletal, psychiatric, gastrointestinal, or autoimmune disorders, * History of surgery involving the abdominal, pelvic, or spinal regions within the past 12 months, * Current pregnancy or suspected pregnancy, * Use of intrauterine devices (IUDs), * Having participated in a regular exercise, sports, or physiotherapy program within the last 6 months, * Concurrent participation in another clinical study.

Conditions

Dysmenorrhea Primary Dysmenorrhea

Locations

Acibadem Mehmet Ali Aydinlar University — Istanbul, Ataşehir, Turkey (Türkiye)

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment